Ketamine Psychedelic Therapy in the Treatment of Heroin Addiction

Investigator: Evgeny Krupitsky, MD, PhD
St. Petersburg, Russia
Sponsor: MAPS, Heffter
Clinical study, drug administration phase completed, 70 patients treated (35 in the experimental and 35 in the control group). The study is finished, the researchers published the six-month follow-up paper in MAPS. The one-year follow-up analysis has been completed. Two year follow-up data has been analyzed and submitted for publication and is currently in the midst of the peer review process. Results are promising.
Research Protocol for the Therapeutic dose vs. Low Dose Placebo study